Specifics of the network model of innovation in pharmaceuticals in the context of intellectual property protection
( Pp. 182-190)

This article is aimed at identifying and analyzing the specifics of the network model of innovation in the pharmaceutical industry in the context of intellectual property protection on the example of a number of foreign countries and Russia. The starting point of the research is the currently observed networking - the introduction of non-market communication, which is beginning to replace purely exchange, monetary regulators in the economy, law, and other spheres of society. The article examines the issue of acceptability (objective necessity) of applying (accepting) «open» innovations in the pharmaceutical industry and some facets of the influence of this trend in the field of law. Specific examples are used to discuss various forms of expression of the open innovation strategy practiced in the pharmaceutical industry and some of its prospects. At the same time, some aspects of the protection of intellectual property rights obtained during the implementation (realization) of the «open» innovation strategy in pharmaceutical sector are studied in the traditional and network (using blockchain technology) format. The relevance, theoretical and practical significance of such a research is due to the fact that both network «open» (innovative) and «closely-held» (traditional) methods of developing new scientific knowledge have their pros and cons, which can currently slow down or accelerate scientific progress and promote innovative growth. Foreign experience can be useful in finding answers to similar questions related to the development, justification and adoption of collaborations based on «open» innovations by our country, and the fact that this study serves to fill in the existing gap in the development of legal and other approaches of foreign countries in the field of modern research. The author's results, among other things, are presented in the fact that currently the protection of intellectual property from unauthorized use is still traditionally based on agreements, but can already be performed in a modern network way - using distributed ledger technology - blockchain, that reliability is due to hardware control over any changes in the protocols or information in the network, its copying, easiness of establishing and verifying its authorship, which increases the chances of successful development of the OI strategy.

Ksenia M.B., (2020), SPECIFICS OF THE NETWORK MODEL OF INNOVATION IN PHARMACEUTICALS IN THE CONTEXT OF INTELLECTUAL PROPERTY PROTECTION. Economic Problems and Legal Practice, 5 => 182-190.

Akhmadova M.A. Nekotorye voprosy pravovogo regulirovaniya bioprintinga v Rossii. Sotsial no-politicheskie nauki. 2020. T. KH. № 2. S. 196-204. DOI: 10.33693/2223-0092-2020-10-2-196-204 i dr.
Belikova K.M. Bioprinting i vyrashchivanie natural nykh tkaney i organov v stranakh BRIKS (na primere Brazilii, Indii, Kitaya i YUAR): podkhody zakonodatel stva ob intellektual noy sobstvennosti // Pravo i politika. - 2020. - № 5. - S. 35-57. DOI: 10.7256/2454-0706.2020.5.32826 URL: https://nbpublish.com/library read article.php id 32826 (data obrashcheniya: 07.06.2020)
Belikova K.M. Osobennosti setevoy modeli innovatsionnoy deyatel nosti v klastere robototekhniki v kontekste zashchity intellektual noy sobstvennosti. // Problemy ekonomiki i yuridicheskoy praktiki. 2020. T. 16. №5 (v pechati).
Belikova K.M. Pravovoe regulirovanie novykh tekhnologiy v meditsine v svete zakonodatel stva ob intellektual noy sobstvennosti i otvetstvennost uchenogo v stranakh BRIKS: monografiya. / K.M. Belikova i dr.; otv. red. Belikova K.M. - M.: MDMPrint, 2020. - S. 432-442 (536 s.).
Blokcheyn na pike khaypa: pravovye riski i vozmozhnosti Tekst / A.YU. Ivanov (ruk. avt. koll.), M.L. Bashkatov, E.V. Galkova i dr.; Nats. issled. un-t Vysshaya shkola ekonomiki , In-t prava i razvitiya VSHE - Skolkovo. - M. : Izd. dom Vysshey shkoly ekonomiki, 2017. - 237 s.
Vorozhevich A.S. Prinuditel noe litsenzirovanie farmpreparatov: chem opasny dlya otrasli i potrebiteley initsiativy FAS Rossii. // Ekonomika i zhizn . - 2017. - № 01 (9667) (13 yanvarya 2017). - S. 14-15. URL: https://ilr.hse.ru/data/2017/02/07/1167426222.pdf (data obrashcheniya: 22.09.2020)
Ioda E.V. O kontseptsii otkrytykh innovatsiy. // Sotsial no-ekonomicheskie yavleniya i protsessy. - 2011. - № 8 (030). - S. 96-101.
Klunko N.S. Innovatsionnaya strategiya farmatsevticheskogo kompleksa. // Izvestiya IGEA. - 2013. - № 3(89). - S. 85-91.
Korolev A., Panov A. Pechat lekarstv na 3D-printere. 11 sentyabrya 2018. URL: https://biomolecula.ru/articles/pechat-lekarstv-na-3d-printere source-3 (data obrashcheniya: 23.09.2020);
Kuznetsov V. Iskusstvennyy intellekt sozdal novoe lekarstvo vsego za 21 den . 04.09.2019. URL: https://hi-news.ru/technology/iskusstvennyj-intellekt-sozdal-novoe-lekarstvo-vsego-za-21-den.html (data obrashcheniya: 14.01.2020)
Makov A.YU. Realizatsiya kontseptsii otkrytykh innovatsiy kak istochnik konkurentnykh preimushchestv farmatsevticheskikh kompaniy. // Innovatsii. - 2011. - № 3(149). - S. 85-88/
Mokhov A.A. Obratnyy effekt. Prinuditel noe litsenzirovanie mozhet sozdat novye problemy. // Rossiyskaya gazeta - Spetsvypusk № 62(8116). 23.03.2020. URL: https://rg.ru/2020 /03/23/prinuditelnoe-licenzirovanie-lekarstv-mozhet-sozdat-novye-problemy.html (data obrashcheniya: 22.09.2020)
Orlova V., Pchelkin A. Raspredelennye reestry. Novye vozmozhnosti i riski storon pri rasporyazhenii isklyuchitel nymi pravami na ob ekty intellektual noy sobstvennosti. // Intellektual nyy vestnik. Informatsionno-analiticheskiy byulleten Pepeliaev Group. 2019. S. 7-11/
Raymond F. Dzhounsa Uroven shuma ( Noise Level ) (1952) / per. YU Loginova // Nauka i zhizn . - 1964. - № 8. - S. 126-136, № 9. - S. 138-145. URL: http://lib.ru/INOFANT/DZHOUNS /noise.txt (data obrashcheniya: 23.09.2020)
Ruzakova O.A., Grin E.S. Primenenie tekhnologii Blockchain k sistematizatsii rezul tatov intellektual noy deyatel nosti // Vestnik Permskogo universiteta. YUridicheskie nauki. - 2017. - № 3. - S. 508-520.
Sem lekarstvennykh preparatov perekhodyat ot Teva pod yurisdiktsiyu Takeda. / Po inf. Of. sayta Takeda. 13 aprelya 2017. URL: https://lekoboz.ru/novosti-kompanij/teva-zaklyuchila-sdelku-s-takeda-na-peredachu-prav-semi-lekarstvennykh-preparatov (data obrashcheniya: 22.09.2020)
Top-10 innovatsionnykh trendov v farme. 27 maya 2019. URL: https://pharma.net.ua/publications/articles/21149-top-10-innovacionnyh-trendov-v-farme (data obrashcheniya: 11.09.20)
Trifilova A.A. Otkrytye innovatsii - paradigma sovremennogo innovatsionnogo menedzhmenta. // Innovatsii. - 2008. - № 1 (111). - S. 73-77.
CHesbro G. Otkrytye innovatsii: sozdanie pribyl nykh tekhnologiy / Genri CHesbro; per. s angl. V. N. Egorova. - Moskva : Pokolenie, 2007. - 336 s.
Eksperimental nye pravovye rezhimy: chto pro nikh nuzhno znat . 01.09.2020. https://www.klerk.ru/blogs/rosco/503872/ (data obrashcheniya: 21.09.2020)
YAponskoe lekarstvo propisalos v Rossii. Takeda lokalizovala proizvodstvo na moshchnostyakh Biokada . // Gazeta Kommersant №58 ot 03.04.2019, str. 10. URL: https://www.kommersant.ru/doc/3931686 (data obrashcheniya: 22.09.2020)
YAstrebova E.V. 1.3. Mul tidistsiplinarnye nauchnye issledovaniya i ikh mediynaya podderzhka. // Problemy ekonomiki i yuridicheskoy praktiki. - 2017. - № 5. - S. 18-22.
Takeda priobrela prava na lekarstva u Unipharm dlya rasprostraneniya v Rossii. 26.01.2018. URL: https://gmpnews.ru/2018/01/takeda-priobrela-prava-na-lekarstva-u-unipharm-dlya-rasprostraneniya-v-rossii/ (data obrashcheniya: 22.09.2020)
Chesbrough H. Open business models. How to thrive in the new innovation landscape, Harvard Business School Press, 2006.
Chesbrough H. Open innovation. the new imperative for creating and profiting from technology, Harvard Business School Press 2003.
Chesbrough, W. Vanhaverbeke, J. West. Open innovation. researching a new paradigm, Oxford University Press, 2006.
Open Innovation in Pharma: The Next Chapter. URL: https://www.inova-software.com/open-innovation-in-pharma-the-next-chapter/ (data obrashcheniya: 22.09.2020)
Printlets. URL: https://www.fabrx.co.uk/printlets/ (data obrashcheniya: 23.09.2020)
West J., Gallagher S. Challenges of open innovation: the paradox of firm investment in open-source software // R D Management. 25 May 2006. https://doi.org/10.1111/j.1467-9310.2006.00436.x

networking, network model of innovation, knowledge growth, pharmaceuticals, intellectual property protection, patents, blockchain.